Arkolith/Insider Trading/INBX/Form 4

Lappe Mark

Chief Executive Officer, DirectorInhibrx Biosciences, Inc. (INBX) · full profile →Form 4 · filed Sep 10, 2024
Net Buying
Open-Market Buys
$671K
Open-Market Sells
$0
Net Open-Market Flow
$671K
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 10, 2024Buy(P)9K$15.19$129K666K
Sep 9, 2024Buy(P)10K$15.21$144K657K
Sep 6, 2024Buy(P)26K$15.29$398K648K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0002007919-24-000045) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML

Keep exploring

Connected pages for Inhibrx Biosciences, Inc.

Build

Ask your agent about INBX insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Get a key Compare plansForm 4 data
Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0002007919-24-000045"
Ask your agent
Use Arkolith to summarize insider buying and selling at Inhibrx Biosciences, Inc.
over the last 90 days and cite the filings.